Navigation Links
Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology
Date:6/4/2009

BRAINTREE, Mass., June 4 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) announced today that the U.S. District Court for the District of Massachusetts has made a ruling in the Company's lawsuit against Fenwal, Inc.

In January 2009, a jury issued a verdict in favor of Haemonetics, finding that Fenwal's ALYX Component Collection System consumable infringes a U.S. Haemonetics patent. The jury awarded Haemonetics $15.7 million in damages for past infringement. On June 2, 2009, the Court further ruled that, in addition to paying the damages awarded by the jury, Fenwal must stop selling the ALYX consumable by December 1, 2010 and must pay Haemonetics a 10% royalty on ALYX consumable net sales from January 30, 2009 until December 1, 2010 when the injunction takes effect. In addition, the court awarded pre-judgment interest at 5% on the unpaid damages awarded. These rulings may be appealed by Fenwal and/or Baxter.

Brian Concannon, Haemonetics' President and CEO, said, "This lawsuit was necessary to protect our Company's intellectual property. Haemonetics remains dedicated to serving the blood collection industry and working with customers to deliver blood management solutions to improve patient care and reduce healthcare costs. We are prepared to support customers through this transition period."

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Haemonetics Announces Launch of Faster Plasma Collection Protocol
2. Haemonetics and Octapharma AG Announce Plasma Collection Technology Contract
3. Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer
4. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
5. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
6. ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema
7. Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use
8. Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
9. 500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
10. SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)
11. Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Peregrine Pharmaceutical... of patient enrollment in a dose confirmation and ...elapsed glioblastoma multiforme (GBM), the deadlie...oclonal antibody linked to a radioisotope being de...ara specifically targets cells at the center of br...
(Date:12/2/2009)...ands, December 2 Pepscan Holding N...using on protein mimicking,technology for the gene... it,has appointed Wim E.M. Mol, Ph.D. as new Chief...ponsible for all of Pepscans corporate functions a...of the company. He brings to,Pepscan more than 20 ...
(Date:12/2/2009)...RNewswire/ -- S*BIO Pte Ltd today announced data p...518, at The American Society of Hematology 51st An...Data will be presented on the clinical results fro...iling its safety, tolerability and pharmacokinetic...nging from 100 to 600 mg. These doses were adminis...
(Date:12/2/2009)...swire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ...rmaceutical company focused on endocrine therapy a...d Drug Administration (FDA) has granted Fast Track...hibitor compound, perifosine (KRX-0401), for the t...Keryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
... have used the world,s thinnest material to create...nd ten atoms wide. , Reporting their peer-reviewe...nce, Dr Kostya Novoselov and Professor Andre Geim ...iversity of Manchester show that graphene can be c...l transistors having a size not much larger than t...
... April 17 Immucor, Inc.,(Nasdaq: BLUD ), a globa...,systems to the blood transfusion industry, announ...e against CEO Gioacchino "Nino" De Chirico has,con...e tribunal in Milan rendered a guilty verdict in t...cash payment of euro 13,500 by Immucor,s,Italian s...
... 17 National Transitions of Care,Coalition (NTOCC... of,recently developed tools for helping healthcar... inherent in transitioning patients from one,level...nation of several,months of collaboration between ...06 to address challenges associated with transitio...
Other Biology Technology:Graphene used to create world's smallest transistor 2Immucor CEO's Italian Trial Moves Toward Second Phase 2Immucor CEO's Italian Trial Moves Toward Second Phase 3Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 2Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 3Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 4Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 5
(Date:12/2/2009)... HOBOKEN, NJ According to the National Institute...diagnosed with diabetes already have some stage of...ge to the retina caused by leaky blood vessels, is...s and is one of the most feared diabetic complicat...ho,ve had diabetes for 10 years or more will exper...
(Date:12/1/2009)...Alzheimer,s disease, nerve cell degeneration plays...tions may possibly be derived from steering the ge...s have been published in the current issue of the ... a few years ago, neurogenesis the process of ner...le in the adult brain. The textbooks asserted that...
(Date:12/1/2009)...ntists, one from the United States, the other from...eader of his wolf pack, on remote Ellesmere Island...to finally find out what these "North Pole wolves"... harshest areas of the world., "We first encount...ech, a renowned U.S. Geological Survey (USGS) wolf...
Breaking Biology News(10 mins):Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3New source discovered for the generation of nerve cells in the brain 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 1Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 2Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 4While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 1While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 2While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 3New Website www loseadresssize com Launches 53709 1New Website www loseadresssize com Launches 53709 2
... Davis researcher known for her honey bee line "Ne...r Old World counterparts to enhance their positive...ry hygienic and very productive, and hopefully wil...," said UC Davis bee breeder-geneticist Susan Cobe...nica ) is a subspecies of the Western honey bee. T...
...From stiff plastic limbs and metal rods to complex...he crash test dummies of yesteryear are evolving a... Medicine are among those bringing them to life. ...epresent live humans with precision and detail not...ll contain detailed representation of the bones an...
...Colorado at Boulder study showing that American to...ir chances of parasitic infections known to cause ... benefits of biodiversity on emerging wildlife dis...d tadpoles were raised in tanks with the parasitic... tadpole limb regions and disrupt normal leg devel...
Other Biology News:Building a better bee 2Wake Forest plays integral role in effort to revolutionize vehicle safety 2Wake Forest plays integral role in effort to revolutionize vehicle safety 3New CU-Boulder study shows diversity decreases chances of parasitic disease 2New CU-Boulder study shows diversity decreases chances of parasitic disease 3
Goat Anti-Bag-1 (K-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Treponema Pallidum IgM ELISA Kit, Single from Bio-Quant Inc.
Treponema Pallidum Total ELISA Kit, Single from Bio-Quant Inc.
Gel Loading Dye (Bromophenol Blue/Glycerol) from Mo Bio Laboratories, Inc.
Biology Products: